ADIPOQ and cancer: In human breast (MCF-7) and hepatic (HepG2) cancer cells adiponectin exerted potent anti-tumor activity via downregulation of estrogen receptor-α expression and blocked leptin-induced estrogen receptor-α activation and suppressed inflammasomes, including NLRP3 and ASC (Raut and Park, 2020).